We have extensive experience and key strategic partnerships across the African continent. In partnership with our main partners ACE Research and MCT, two CROs operating right across Africa, we bring expertise in more than 27 African countries with specialties in infectious diseases, sickle-cell anemia, and oncology

ICON experience in Africa and the Middle East

  • 27 African and Middle East countries

  • 10,000+ patients

  • 20 + years’ experience in Africa
File Thumbnail

The evolution of HIV treatments: From antiretroviral therapy to vaccines, where we are today and what’s next

This whitepaper looks at the significant advancements in the management of human immunodeficiency virus (HIV) over the past decade and where treatment is going in the decade ahead

File Thumbnail

Malaria factsheet

This factsheet outlines the work we have done for nearly 30 years to help eradicate Malaria

More than 25 years ago, we began working with the US Army in Kenya to aid in development of treatments and preventions for malaria. Building on that platform, we continue to participate in clinical trial operations, and training to support disease surveillance, for the US government, NGOs, and Biopharma.

With offices in key locations in West Africa, and our network of accredited laboratories, clinical research sites and strategic partners throughout Sub-Saharan Africa, ICON can provide staff on the ground, providing rapid site selection, initiation, and staff training and patient enrolment in a total of 27 African countries and Middle East countries.

Ebola virus disease

Our longstanding relationships within sub-Saharan Africa uniquely positioned us to be on the ground in the 2014 Ebola hotzone. Our work related to Ebola Virus Disease (EVD) continues with longitudinal studies of EVD survivors and their communities.

File Thumbnail

In the hotzone: Fighting the Ebola Epidemic

Case study on the Ebola crisis and how ICON is helping fight against the epidemic